JunD and HIF-1α mediate transcriptional activation of angiotensinogen by TGF-β1 in human lung fibroblasts

FASEB Journal

Volumn 23, Issue 6, 2009, Pages 1655-1662

  Abdul Hafez, Amal ^a   Shu, Ruijie ^a   Uhal, Bruce D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Activation protein 1; Angiotensinogen promoter; Idiopathic pulmonary fibrosis; Local angiotensin system

Indexed keywords

ANGIOTENSINOGEN; DACTINOMYCIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MESSENGER RNA; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND; TRANSFORMING GROWTH FACTOR BETA1; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN C JUN; PROTEIN SYNTHESIS INHIBITOR;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HALF LIFE TIME; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOLOGY; FIBROBLAST; GENE SILENCING; GENETICS; LUNG; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REPORTER GENE; RNA STABILITY; SWINE;

ANGIOTENSINOGEN; ANIMALS; BASE SEQUENCE; CELL LINE; DACTINOMYCIN; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LUNG; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; RNA STABILITY; SWINE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67649354548     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-114611     Document Type: Article

References (37)

1. Weber, K. T., and Sun, Y. (2000) Recruitable ACE and tissue repair in the infarcted heart. J. Renin Angiotensin Aldosterone Syst. 1, 295-303
2. Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., and Fukui, H. (2001) Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34, 745-7501 (Pubitemid 32927999)
3. Klahr, S., and Morrissey, J. J. (1997) Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int. Suppl. 63, S111-S114 (Pubitemid 28020447)
4. Ko, S. H., Hong, O. K., Kim, J. W., Ahn, Y. B., Song, K. H., Cha, B. Y., Son, H. Y., Kim, M. J., Jeong, I. K., and Yoon, K. H. (2006) High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J. Cell. Biochem. 98, 343-355
5. Marshall, R. P., Gohlke, P., Chambers, R. C., Howell, D. C., Bottoms, S. E., Unger, T., McAnulty, R. J., and Laurent, G. J. (2004) Angiotensin II and the fibroproliferative response to acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L156-L164 (Pubitemid 38055871)
6. Uhal, B. D., Kim, J. K., Li, X., and Molina-Molina, M. (2007) Angiotensin-TGF-β1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr. Pharm. Des. 13, 1247-1256 (Pubitemid 46739332)
7. Wang, R., Ibarra-Sunga, O., Verlinski, L., Pick, R., and Uhal, B. D. (2000) Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L143-L151 (Pubitemid 30619534)
8. Li, X., Rayford, H., Shu, R., Zhuang, J., and Uhal, B. D. (2004) Essential role for cathepsin D in bleomycin-induced apoptosis of alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L46-L51 (Pubitemid 38787649)
9. Li, X., Zhang, H., Soledad-Conrad, V., Zhuang, J., and Uhal, B. D. (2003) Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L501-L507 (Pubitemid 36231728)
10. Uhal, B. D., Joshi, I., True, A. L., Mundle, S., Raza, A., Pardo, A., and Selman, M. (1995) Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 269, L819-L828 (Pubitemid 3020631)
11. Uhal, B. D., Joshi, I., Hughes, W. F., Ramos, C., Pardo, A., and Selman, M. (1998) Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 275, L1192-L1199 (Pubitemid 29029121)
12. Wang, R., Ramos, C., Joshi, I., Zagariya, A., Pardo, A., Selman, M., and Uhal, B. D. (1999) Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am. J. Physiol. Lung Cell. Mol. Physiol. 277, L1158-L1164 (Pubitemid 30046043)
13. Li, X., Molina-Molina, M., Abdul-Hafez, A., Ramirez, J., Serrano- Mollar, A., Xaubet, A., and Uhal, B. D. (2006) Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L887-L895 (Pubitemid 44772050)
14. Flanders, K. C. (2004) Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85, 47-64
15. Kagami, S., Border, W. A., Miller, D. E., and Noble, N. A. (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest. 93, 2431-2437 (Pubitemid 24177156)
16. Campbell, S. E., and Katwa, L. C. (1997) Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J. Mol. Cell. Cardiol. 29, 1947-1958
17. Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., and Fukui, H. (2001) Angiotensin- II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34, 745-750 (Pubitemid 32927999)
18. Marshall, R. P., McAnulty, R. J., and Laurent, G. J. (2000) Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am. J. Respir. Crit. Care Med. 161, 1999-2004
19. Olive, M., Krylov, D., Echlin, D. R., Gardner, K., Taparowsky, E., and Vinson, C. (1997) A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J. Biol. Chem. 272, 18586-18594 (Pubitemid 27318198)
20. Sherman, C. T., and Brasier, A. R. (2001) Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin- 6. Mol. Endocrinol. 15, 441-457
21. Krick, S., Eul, B. G., Hänze, J., Savai, R., Grimminger, F., Seeger, W., and Rose, F. (2005) Role of hypoxia-inducible factor-1alpha in hypoxia-induced apoptosis of primary alveolar epithelial type II cells. Am. J. Respir. Cell Mol. Biol. 32, 395-403 (Pubitemid 40629324)
22. Ray, S., Boldogh, I., and Brasier, A. R. (2005) STAT3 NH2- terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology 129, 1616-1632 (Pubitemid 41597401)
23. Eickelberg, O., Pansky, A., Koehler, E., Bihl, M., Tamm, M., Hildebrand, P., Perruchoud, A. P., Kashgarian, M., and Roth, M. (2001) Molecular mechanisms of TGF-β antagonism by interferon-γ and cyclosporine A in lung fibroblasts. FASEB J. 15, 797-806 (Pubitemid 32245998)
24. Jiang, Y., Dai, A., Li, Q., and Hu, R. (2007) Hypoxia induces transforming growth factor-beta1 gene expression in the pulmonary artery of rats via hypoxia-inducible factor-1alpha. Acta Biochim. Biophys. Sin. (Shanghai) 39, 73-80 (Pubitemid 46115039)
25. Shi, Y. F., Fong, C. C., Zhang, Q., Cheung, P. Y., Tzang, C. H., Wu, R. S., and Yang, M. (2007) Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway. FEBS Lett. 581, 203-210 (Pubitemid 46096462)
26. McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., and Dubois, C. M. (2006) Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem. 281, 24171-24181 (Pubitemid 44274191)
27. Tzouvelekis, A., Harokopos, V., Paparountas, T., Oikonomou, N., Chatziioannou, A., Vilaras, G., Tsiambas, E., Karameris, A., Bouros, D., and Aidinis, V. (2007) Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am. J. Respir. Crit. Care Med. 176, 1108-1119 (Pubitemid 350223757)
28. Shah, R., Hurley, C. K., and Posch, P. E. (2006) A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP-509C-T (c.-1347C>T). Hum. Genet. 120, 461-469 (Pubitemid 44669781)
29. Pfäfflin, A., Brodbeck, K., Heilig, C. W., Häring, H. U., Schleicher, E. D., and Weigert, C. (2006) Increased Glucose Uptake and Metabolism in Mesangial Cells Overexpressing Glucose Transporter 1 Increases Interleukin-6 and Vascular Endothelial Growth Factor Production: Role of AP-1 and HIF-1α. Cell. Physiol. Biochem. 18, 199-210
30. Jeunemaitre, X. (2004) Genetics of the human rennin-angiotensin system. In Handbook of Experimental Pharmacology Angiotensin, Vol.163 (Unger, T., and Schölkens, B. A., eds) pp. 173-206, Springer, New York
31. Inoue, I., Nakajima, T., Williams, C. S., Quackenbush, J., Puryear, R., Powers, M., Cheng, T., Ludwig, E. H., Sharma, A. M., Hata, A., Jeunemaitre, X., and Lalouel, J. M. (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 99, 1786-1797 (Pubitemid 27164639)
32. Xiao, F., Wei, H., Song, S., Li, G., and Song, C. (2006) Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B. J. Gastroenterol. Hepatol. 21, 1488-1491 (Pubitemid 44154722)
33. Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A. D., Crawford, D. H., Shorthouse, C., Purdie, D. M., and Jonsson, J. R. (2000) Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31, 828-833 (Pubitemid 30169926)
34. Dixon, J. B., Bhathal, P. S., Jonsson, J. R., Dixon, A. F., Powell, E. E., and O'Brien, P. E. (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J. Hepatol. 39, 967-971
35. Xaubet, A., Marin-Arguedas, A., Lario, S., Ancochea, J., Morell, F., Ruiz-Manzano, J., Rodriguez-Becerra, E., Rodriguez-Arias, J. M., Inigo, P., Sanz, S., Campistol, J. M., Mullol, J., and Picado, C. (2003) Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 168, 431-435 (Pubitemid 37046871)
36. Molina-Molina, M., Xaubet, A., Li, X., Abdul-Hafez, A., Friderici, K., Jernigan, K., Fu, W., Ding, Q., Pereda, J., Serrano-Mollar, A., Casanova, A., Rodríguez-Becerra, E., Morell, F., Ancochea, J., Picado, C., and Uhal, B. D. (2008) Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression. Eur. Respir. J. 32, 1004-1008
37. Yazgan, O., and Pfarr, C. M. (2002) Regulation of two JunD isoforms by Jun N-terminal kinases. J. Biol. Chem. 277, 29710-29718